Impact of disease‐modifying therapies on humoral and cellular immune‐responses following SARS‐CoV‐2 vaccination in MS patients

• Autori principali: Susan Trümpelmann (Autore), Andreas Schulte‐Mecklenbeck (Autore), Olga V. Steinberg (Autore), Timo Wirth (Autore), Manfred Fobker (Autore), Lisa Lohmann (Autore), Jan D. Lünemann (Autore), Heinz Wiendl (Autore), Catharina C. Gross (Autore), Luisa Klotz (Autore)
• Natura: Libro
• Pubblicazione: Wiley, 2022-07-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Abstract The impact of distinct disease‐modifying therapies (DMTs) on severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) vaccination efficacy in patients with multiple sclerosis (MS) is still enigmatic. In this prospective comparative study, we investigated humoral and cellular immune‐resp...